PET Imaging of Noradrenergic Transmission in the Brain

Publication date: Jul 06, 2026

Background: Researchers have developed a new radioactive tracer (11C-ARMI). A tracer is a drug that attaches itself to other chemicals in the body and lights up so that the chemicals can be seen in imaging scans. The new tracer may be able to help them with many diseases, such as Alzheimer s disease and Parkinson s disease. Researchers want to test the new tracer in healthy people. Objective: To test a new tracer (11C-ARMI) during imaging scans of the brain and body in healthy people. Eligibility: Healthy people aged 18 years and older. They must have been screened under protocols 01-M-0254 or 17M0181. Design: All participants will have a positron emission tomography (PET)/computed tomography (CT) scan. Before the scan, they will have blood and urine tests and a test of their heart function. The tracer will be given through a tube attached to a needle inserted into a vein in the arm. They will lie on a padded bed that fits inside a doughnut-shaped machine; the machine uses x-rays to create images of the inside of the body. Some participants will have a PET/CT scan of their whole body. They will need only 1 visit. Some participants will have a PET/CT scan of only their brain. They will have up to 2 visits. On the second visit, they will have a magnetic resonance imaging (MRI) scan of the brain. For the MRI, they will lie on a table that slides into a cylinder. The MRI uses magnetic fields to create images of the inside of the body. Participants will receive a follow-up call to check on their well-being after their PET/CT scans.

Concepts Keywords
Doughnut 11C-ARMI
Hiv Healthy
Mri
Volunteers

Semantics

Type Source Name
disease MESH bed
disease MESH Anxiety Disorders
disease MESH foreign objects
drug DRUGBANK Creatinine
drug DRUGBANK Dextrose unspecified form
drug DRUGBANK Urea
drug DRUGBANK Nitrogen
disease MESH claustrophobia
disease MESH HIV infection
pathway REACTOME HIV Infection
disease MESH substance use disorder
disease MESH alcohol use disorder
disease MESH aneurysm
pathway REACTOME Adrenoceptors
drug DRUGBANK Norepinephrine
pathway REACTOME Release
disease MESH PDE
drug DRUGBANK Sildenafil
drug DRUGBANK Tadalafil
drug DRUGBANK Vardenafil
disease MESH hypersensitivity
drug DRUGBANK Prazosin

Original Article

(Visited 46 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *